These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3804459)
1. Immunocytochemical mapping of IgE/IgG binding sites within the birch pollen grain using serum from a patient undergoing hyposensitization therapy. Comparison with biochemically determined data. Grote M; Kalveram K; Fromme HG; Forck G Int Arch Allergy Appl Immunol; 1987; 82(2):147-52. PubMed ID: 3804459 [TBL] [Abstract][Full Text] [Related]
2. Immunoautoradiographic and protein-A/gold labelling experiments for localization of pollen allergens using antisera from atopic human individuals. Fromme HG; Grote M; Sinclair NJ; Kalveram K Histochemistry; 1985; 82(4):391-6. PubMed ID: 3874192 [TBL] [Abstract][Full Text] [Related]
3. [IgE and IgG antibody response in patients with type I allergy to birch pollen]. Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932 [TBL] [Abstract][Full Text] [Related]
4. Effect of hyposensitization for tree pollinosis on associated apple allergy. Herrmann D; Henzgen M; Frank E; Rudeschko O; Jäger L J Investig Allergol Clin Immunol; 1995; 5(5):259-67. PubMed ID: 8574432 [TBL] [Abstract][Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565 [TBL] [Abstract][Full Text] [Related]
6. Visualization of birch pollen allergens using IgE-containing sera from human atopic individuals in immunogold labelling experiments. Grote M; Fromme HG Histochem J; 1986 Jan; 18(1):24-8. PubMed ID: 3486858 [TBL] [Abstract][Full Text] [Related]
7. Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. Visco V; Dolecek C; Denépoux S; Le Mao J; Guret C; Rousset F; Guinnepain MT; Kraft D; Valenta R; Weyer A; Banchereau J; Labecque S J Immunol; 1996 Jul; 157(2):956-62. PubMed ID: 8752951 [TBL] [Abstract][Full Text] [Related]
8. A long-term follow-up study of hyposensitization with immunoblotting. Jarolim E; Poulsen LK; Stadler BM; Mosbech H; Oesterballe O; Kraft D; Weeke B J Allergy Clin Immunol; 1990 Jun; 85(6):996-1004. PubMed ID: 2355159 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. Wachholz PA; Soni NK; Till SJ; Durham SR J Allergy Clin Immunol; 2003 Nov; 112(5):915-22. PubMed ID: 14610480 [TBL] [Abstract][Full Text] [Related]
10. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of blocking antibodies by RAST interference during pollen desensitization: role of the IgG fraction. Chien YK; Anfosso F; Vervloet D; Charpin J Biomed Pharmacother; 1982; 36(3):145-9. PubMed ID: 7150707 [TBL] [Abstract][Full Text] [Related]
12. Quantity and avidity of antibodies against birch pollen in atopic patients during hyposensitization. A preliminary study. Ahlstedt S; Belin L; Eriksson NE; Hanson LA Int Arch Allergy Appl Immunol; 1975; 48(5):632-41. PubMed ID: 1132912 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide. Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093 [TBL] [Abstract][Full Text] [Related]
15. Hyposensitization therapy with whole pollen extract or purified allergens monitored by immunoblotting. Jarolim E; Matthiesen F; Skov PS; Tejkl M; Oesterballe O; Poulsen LK Int Arch Allergy Appl Immunol; 1990; 92(3):254-64. PubMed ID: 1703516 [TBL] [Abstract][Full Text] [Related]
16. Expression of birch pollen-specific IgE-binding activity in seeds and other plant parts of birch trees (Betula verrucosa Ehrh.). Fountain DW; Berggren B; Nilsson S; Einarsson R Int Arch Allergy Immunol; 1992; 98(4):370-6. PubMed ID: 1422264 [TBL] [Abstract][Full Text] [Related]
17. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses. Ejrnaes AM; Bodtger U; Larsen JN; Svenson M Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926 [TBL] [Abstract][Full Text] [Related]
18. [Hyposensitization with cross-reacting pollen allergens]. Karl S; Rakoski J Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627 [TBL] [Abstract][Full Text] [Related]
19. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice. Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026 [TBL] [Abstract][Full Text] [Related]
20. Binding of antibodies against birch pollen antigens/allergens to various parts of apples as studied by immuno-gold electron microscopy. Grote M Immunobiology; 1988 Feb; 176(3):290-300. PubMed ID: 3360466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]